Large Language Models as Clinical Nutrition Decision Tools: Quantitative Bias and Guideline Deviation in Type 2...

Background/Objectives: Large language models (LLMs) are increasingly used as decision support tools in clinical nutrition, including meal planning for individuals with type 2 diabetes mellitus (T2DM). However, the clinical safety, quantitative accuracy, and guideline adherence of AI-generated dietary plans remain uncertain. This study aimed to evaluate systematic bias and agreement between LLM-generated diets and a guideline-concordant reference diet, and to assess whether current LLMs can function as reliable clinical nutrition decision support tools in T2DM. Methods: Six widely used LLMs generated standardized three-day, 1800 kcal dietary plans for T2DM using an identical prompt. Each day was treated as an independent observation (n = 18). Energy and macronutrient contents were analyzed using professional nutrition software and compared with a dietitian-designed reference diet based on ADA, EASD, IDF, and national guidelines. Agreement was evaluated using Bland-Altman analysis, proportional bias assessment, and intraclass correlation coefficients. Guideline adherence and clinical appropriateness were independently scored by registered dietitians. Results: Most LLM-generated diets systematically deviated from the reference diet, with lower total energy, reduced carbohydrate and fiber content, and variable protein distribution. Bland-Altman analyses demonstrated significant bias and wide limits of agreement for key nutrients, indicating clinically meaningful discrepancies. Guideline adherence scores varied substantially across models, with only one model showing relatively consistent performance. Inter-rater reliability between dietitians was high (ICC = 0.806). Conclusions: Current LLMs exhibit systematic quantitative bias and inconsistent guideline adherence when used for T2DM meal planning. AI-generated dietary plans are not interchangeable with dietitian-guided medical nutrition therapy and may pose clinical risks if used without professional oversight. Careful validation, domain-specific fine-tuning, and integration within supervised clinical workflows are required before implementation in diabetes care.